Healthcare

Consistent with the firm’s overall focus, ROTH’s Healthcare banking team assists in the development of financing and growth strategies for public (or soon-to-be-public) small-cap companies. Our clients cover a broad spectrum of sectors including companies engaged in the clinical development of new therapeutic compounds, drug discovery techniques, medical technologies and devices. In some cases these companies require cash to complete the development of their product portfolio, while others need capital to fund the commercial launch of their programs. We also work closely with management and the Board of Directors in evaluating acquisition opportunities, licenses and strategic partnerships to accelerate growth and enhance shareholder value. We offer a full array of investment banking products and services including public and private offerings of equity and debt, advisory services and recapitalizations.

Our sub-sector focus includes:

• Specialty pharmaceuticals

• Medical technologies and devices

• Biotechnology

• Healthcare services and IT

• China

Select Transactions:
(Click Here for additional Healthcare Transactions)

Contacts

John Chambers
Vice-Chairman and
Head of Healthcare
Investment Banking
New York
646-358-1901
jchambers@roth.com

Michael Margolis, R.Ph.
Managing Director
New York
646-358-1902
mmargolis@roth.com

Warren Dunnavant II
Director
New York
646-358-1903
wdunnavant@roth.com

Adam Stormoen
Director
Minneapolis
612-720-8136
astormoen@roth.com